 So we'll have to wait for those results. But this sounds very promising. Is the process you're using adaptable to other brain diseases where, I don't know, there might be other proteins which you'd like to regulate, things like Alzheimer's, I don't know if Parkinson's or a disease like that might be appropriate for this kind of approach? Yes. So we think any disease in which there's a natural protein that's contributing to the disease process could be applicable.